MicroRNAs - Future drug targets.?
MicroRNAs - Future drug targets.?
复制标题
DOI:
10.1002/anie.200601537
复制
发表时间:
2006-01-01
影响因子:
16.6
通讯作者:
Arenz, Christoph
中科院分区:
文献类型:
--
作者:
Arenz, Christoph
A growing body of evidence suggests that gene regulation in eukaryotes takes place to a large extent on the RNA level.[1] A group of endogenous regulatory RNA molecules, the so-called microRNAs (miRNAs), are being intensively examined by biologists and physicians. These small RNA molecules are not only believed to be involved in the regulation of nearly 30% of all human genes [2] but an ever-increasing amount of data points towards a connection between specific changes in miRNA expression patterns and various diseases.MicroRNAs are formed in the cell nucleus from so-called primary micro-RNAs (pri-miRNAs, Figure1). These transcripts can be produced either autonomously under the control of a specific promoter or from the intron of a protein-encoding primary transcript through RNA polymeraseII. One or more precursor miRNAs (pre-miRNAs) are then formed by cleavage of the primiRNAs by the ribonuclease Drosha. These pre-miRNAs are made up of 70–80 nucleotides and exhibit a typical hairpin conformation. The pre-miRNAs are transported out of the nucleus into the cytosol by the protein exportin 5. In the cytosol, the ribonuclease Dicer then nucleolytically cleaves both strands of the helical stem. The resulting miRNA is